The company's strategy centers around advancing its pipeline of protein, antibody, and small molecule drugs for the treatment of oncology, inflammatory diseases, and diabetes. Founded in 1991 and headquartered in Branford, Connecticut, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.